Evotec SE ( EVO) - Stock Earnings
EVO Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 13, 2026, midnight | — / — | — | — / — | — |
EVO Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -50.6 million USD | 192.3 million USD |
| 2025Q4 | 17.2 million USD | 297.3 million USD |
| 2026Q1 | -142.0 million USD | 182.5 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
EVO Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -92.8 million USD | 863.8 million USD |
| 2024 | -204.2 million USD | 829.9 million USD |
| 2025 | -116.7 million USD | 889.0 million USD |
| 2026 Est. | — | — |
EVO
Price: $1.95
Earnings Per Share: -0.64 USD
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Germany
Volume: 14985
Market Capitalization: 1.0 billion